
Secure future manufacturing for advanced therapies
One critical bottleneck in Cell and Gene Therapy (CGT) manufacturing is the production of high-quality plasmid DNA (pDNA), a vital building block for mRNA-based vaccines, viral vector-based cell, or gene therapies that require pDNA as a starting material. Watch this free webinar – Early phase support for plasmid DNA supply… Read More












